Kunitachi, Japan

Kazuyuki Iwahashi

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuyuki Iwahashi. Retrieved from https://idiyas.com/inventor/kazuyuki-iwahashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuyuki Iwahashi: Innovator in Antiallergic Substances

Introduction

Kazuyuki Iwahashi is a notable inventor based in Kunitachi, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of physiologically active substances. His work has implications for medical treatments, especially in addressing allergic reactions.

Latest Patents

Iwahashi holds a patent for a novel physiologically active substance known as K-252. This substance exhibits antiallergic action and is produced through the culturing of a microorganism from the genus Nocardiopsis. His innovative approach in this area showcases his commitment to advancing medical science.

Career Highlights

Kazuyuki Iwahashi is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its research and development in pharmaceuticals and biotechnology. His role in the company has allowed him to explore and develop new therapeutic agents that can benefit patients suffering from allergies.

Collaborations

Iwahashi has worked alongside esteemed colleagues such as Yuzuru Matsuda and Kozo Asano. Their collaborative efforts have contributed to the success of various projects within the company, enhancing the overall impact of their research.

Conclusion

Kazuyuki Iwahashi's work in developing K-252 represents a significant advancement in the field of antiallergic substances. His contributions continue to influence the pharmaceutical industry and improve the quality of life for individuals with allergies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…